We investigated the incidence of ocular bleeding in patients taking anticoagulant therapy (warfarin) and its association with other related factors. We examined 210 patients taking warfarin and 210 gender- and age-matched controls for ocular bleeding. Patients and controls were examined by external ocular exam-ination and fundoscopic examination. The incidence of ocular bleeding was 11.4 % in patients and 3.8 % in controls. It was five times higher in patients with hypertension than in other patients. The incidence of ocular bleeding was higher in older than in younger patients. No association was found between ocular bleeding and factors such as gender, international normalized ratio, duration of warfarin therapy, concomitant aspirin use a...
Copyright © 2014 Eric Puroll et al. This is an open access article distributed under the Creative Co...
We report a case of spontaneous hyphaema with no apparent predisposing cause except the assumption o...
Background: Warfarin is widely used anticoagulant in treatment and prevention of thrombosis. Despite...
We investigated the incidence of ocular bleeding in patients taking anticoagulant therapy (warfarin)...
Deep vein thrombosis, pulmonary embolism, ischemic stroke and myocardial infarction are the major th...
Background and Objectives: There are multiple factors associated with the risk of bleeding for patie...
Copyright © 2014 Evren Uygungül et al.This is an open access article distributed under theCreativeC...
Bleeding is the most important complication of oral anticoagulation (OAC) with vitamin K-antagonists...
The most common indication for treatment with warfarin is the prevention of ischemic stroke in patie...
Objectives: Warfarin-induced bleedingresults in increased morbidity and mortality and higher cost of...
PurposeWarfarin management in the elderly population is complex as medicines prescribed for concomit...
Purpose: 1-to define the prevalence of hemorrhagic retinopathy in patients treted with oral anticoag...
Purpose: The purpose of this study was to investigate the effect of systemic antiplatelet agents and...
Published online July 6, 2017.Importance: It is unclear if the risk of intraocular bleeding with nov...
Objectives: Warfarin is used in prophylaxis and treatmentof many diseases. Low doses of warfarin inc...
Copyright © 2014 Eric Puroll et al. This is an open access article distributed under the Creative Co...
We report a case of spontaneous hyphaema with no apparent predisposing cause except the assumption o...
Background: Warfarin is widely used anticoagulant in treatment and prevention of thrombosis. Despite...
We investigated the incidence of ocular bleeding in patients taking anticoagulant therapy (warfarin)...
Deep vein thrombosis, pulmonary embolism, ischemic stroke and myocardial infarction are the major th...
Background and Objectives: There are multiple factors associated with the risk of bleeding for patie...
Copyright © 2014 Evren Uygungül et al.This is an open access article distributed under theCreativeC...
Bleeding is the most important complication of oral anticoagulation (OAC) with vitamin K-antagonists...
The most common indication for treatment with warfarin is the prevention of ischemic stroke in patie...
Objectives: Warfarin-induced bleedingresults in increased morbidity and mortality and higher cost of...
PurposeWarfarin management in the elderly population is complex as medicines prescribed for concomit...
Purpose: 1-to define the prevalence of hemorrhagic retinopathy in patients treted with oral anticoag...
Purpose: The purpose of this study was to investigate the effect of systemic antiplatelet agents and...
Published online July 6, 2017.Importance: It is unclear if the risk of intraocular bleeding with nov...
Objectives: Warfarin is used in prophylaxis and treatmentof many diseases. Low doses of warfarin inc...
Copyright © 2014 Eric Puroll et al. This is an open access article distributed under the Creative Co...
We report a case of spontaneous hyphaema with no apparent predisposing cause except the assumption o...
Background: Warfarin is widely used anticoagulant in treatment and prevention of thrombosis. Despite...